Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLN2704 in metastatic androgen-independent prostate cancer
NCT00070837Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Oct 2003
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MLN2704 in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Millennium Pharmaceuticals. Started Oct 2003; status: completed.
02
Drugs
MLN2704
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT00070837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070837.